Research Article: Characteristics, Outcomes, and Clinical Indicators of Bloodstream Infections in Neutropenic Patients with Hematological Malignancies: A -Year Retrospective Study
Introduction:
Patients with hematological malignancies (HMs) are exposed to a high risk of infectious complications because they become immunocompromised due to either the underlying disease or the cytotoxic effects of chemotherapy. Bacterial bloodstream infections (BSIs) are one of the most common complications for patients with HMs, which results in high mortality and morbidity. This is especially true for patients with chemotherapy-induced neutropenia. BSI, defined as laboratory-confirmed isolation of at least one…
Read more